The venture capital market is showing signs of normalization, which is encouraging news for numerous healthcare startups seeking funding. According to a recent report from CB Insights, global venture funding reached $65.7 billion in the second quarter of 2024. Despite a decrease in deal volume, the average deal size has risen by 17%, now standing at $14.4 million compared to last year’s $12.3 million.
A separate report from Rock Health indicates that digital health venture funding for 2024 is set to surpass the totals from 2019 and 2023. Specifically, U.S. digital health startups secured $5.7 billion across 266 deals in the first half of this year. For context, the annual fundraising totals for digital health in 2019 and 2023 were $8.2 billion and $10.7 billion, respectively.
Early-stage transactions, including seed, Series A, and Series B rounds, dominated the first half of 2024, comprising 84% of all deals. Notably, Series A activity was robust, with a median deal size of $15 million, up from $12 million last year. Prominent funding rounds included Zephyr AI’s $111 million raise in March and Allez Health’s $60 million raise in May.
Rock Health’s analysis also observed a decline in unlabeled funding rounds—those without a traditional letter designation such as “Series B” or “Series C.” In the first half of 2024, 40% of deals were unlabeled, down from a peak of 55% in Q4 2023.
The market has also seen some exits after a prolonged lull. Three digital health companies exited the startup sphere in the second quarter: Nuvo exited via a SPAC merger in May, and Waystar and Tempus AI both launched IPOs in June.
Keith Figlioli, managing partner at LRVHealth, expressed optimism about these trends. He stated, “Good companies will find their way to solid growth, and capital will be available for those with proven, durable business models and attractive unit economics.” Figlioli expects venture capital to hover around $10 billion annually, indicating a stable investment environment.
For more details, you can read the full article on MedCity News.